Total
0
Shares
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • HempFusion Wellness (CBD.U) has increased the size of its non-brokered private placement to over US$2,500,000 due to demand from retail investors
  • The closing of the offering has been extended to September 30, 2021
  • HempFusion announces that David Doherty has resigned as a director of the company
  • HempFusion Wellness, a health & wellness CBD company, distributes its family of brands to 15,000 retail locations across the United States and internationally
  • HempFusion Wellness (CBD.U) is up 6.25 per cent, trading at C$0.245 per share at 12:45 pm ET

HempFusion Wellness (CBD.U) has increased the size of its previously announced non-brokered private placement to over US$2,500,000.

“We received quite a few requests from our large network of retail investors, brokers, and funds, to allow further access into this small strategic private placement,” commented Dr. Jason Mitchell, HempFusion’s Co-founder and Chief Executive Officer.

“While we continue to maintain a strong balance sheet, the incoming funds represent strong investors with expected long term time horizons, and we’re excited to welcome them into our company at such a pivotal time.”

The closing of the offering has been extended to September 30, 2021, and remains subject to the approval of the Toronto Stock Exchange.

In other news, HempFusion announces that David Doherty has resigned as a director of the company effective September 17, 2021. The board of directors of the company expresses their appreciation to Mr. Doherty for his contributions.

HempFusion is a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition. HempFusion Wellness Inc. distributes its family of brands, including HempFusion, Probulin Probiotics, Sagely Naturals, and Apothecanna, to approximately 15,000 retail locations across the U.S. and select international locations. 

HempFusion Wellness (CBD.U) is up 6.25 per cent, trading at C$0.245 per share at 12:45 pm ET.

More From The Market Herald

" Andlauer Healthcare Group (TSX:AND) completes $169M bought deal offering

Andlauer Healthcare Group Inc. (AND) and Andlauer Management Group Inc. completed a bought deal offering of 3.5 million subordinate voting shares (SVSs).

" Avricore (TSXV:AVCR) expands HealthTab to select Shoppers Drug Mart locations in BC

Avricore Health (AVCR) has expanded its patient testing with the HealthTab platform in select Shoppers Drug Mart pharmacies in BC.

" Clearmind (CSE:CMND) signs development and supply agreement with Aragen Life Sciences

Clearmind Medicine (CMND) will work with Aragen Life Sciences to produce its innovative molecule, 5-Methoxy-2-aminoindane (MEAI).

" Aptose (TSX:APS) expands senior leadership team

Aptose Biosciences (TSX: APS) has appointed two key members to its management team to support its finance and operations functions.